The Effects of Ginger Supplementation on Lipid Profile: A Meta-Analysis of Randomized Clinical Trials
Abstract
AbstractBackground: Some, but not all, experimental and clinical studies have suggested that ginger supplementation has beneficial effects on serum lipid profiles. Therefore, we conducted a meta-analysis to evaluate the ginger supplementation on human serum lipids.Methods: Systematic search for English published randomized controlled trials (RCTs) was performed up to April 2016 through electronic databases: Medline, EMBASE and Google Scholar. A total of seven RCTs were met inclusion criteria. The pooled weighted mean difference (MD) and its 95% confidence interval (CI) were calculated and pooled using using a random-effects model.Results: Ginger supplementation was associated with a significant reduction in mean serum total cholesterol (-13.31 mg/dL, 95% CI, -20.29 to -6.33 mg/dL, P=0.000), low-density lipoprotein cholesterol (-11.22 mg/dL; 95% CI, -18.37 to -4.06 mg/dL, p = 0.002), triglycerides ( -14.96 mg/dL; 95% CI, -22.13 to -7.79 mg/dL, p = 0.000); Increasing in high-density lipoprotein cholesterol level was not statistically significant (WMD = 0.12 mg/dL; 95% CI, -1.01 to 1.24 mg/dL, p =0.839.Conclusion: Ginger supplementation significantly improved lipid profile (LDL, TG and TC) and it may be an effective intervention for managing serum lipid status. Further, high-quality RCTs are required to identifying the ginger supplementation effects on HDL.References
References
Bhandari U, Sharma J, Zafar R. The protective action of ethanolic ginger (Zingiber officinale) extract in cholesterol fed rabbits. Journal of Ethnopharmacology. 1998;61(2):167-71.
Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. The Lancet. 2006;367(9524):1747-57.
Holick MF. Vitamin D deficiency. New England Journal of Medicine. 2007;357(3):266-81.
Hietanen J, Salo O. Pemphigus: an epidemiological study of patients treated in Finnish hospitals between 1969 and 1978. Acta dermato-venereologica. 1981;62(6):491-6.
Elshater A, Salman MM, Moussa MM. Effect of ginger extract consumption on levels of blood glucose, lipid profile and kidney functions in alloxan induced-diabetic rats. Egyptian Academic Journal of Biological Sciences. 2009;2(1):153-62.
Leong DJ, Choudhury M, Hirsh DM, Hardin JA, Cobelli NJ, Sun HB. Nutraceuticals: potential for chondroprotection and molecular targeting of osteoarthritis. International journal of molecular sciences. 2013;14(11):23063-85.
Nicoll R, Henein MY. Ginger (Zingiber officinale Roscoe): a hot remedy for cardiovascular disease? International journal of cardiology. 2009;131(3):408-9.
Ensminger ME, Ensminger AH. Foods & Nutrition Encyclopedia, Two Volume Set: CRC press; 1993.
Balducci S, Leonetti F, Di Mario U, Fallucca F. Is a long-term aerobic plus resistance training program feasible for and effective on metabolic profiles in type 2 diabetic patients? Diabetes Care. 2004;27(3):841-2.
Shirdel Z, Mirbadalzadeh R, Madani H. Antidiabetic and antilipidemic effect of ginger in alloxan monohydrate diabetic rats in comparison with glibenclamide. Iran J Diabetes Lipid Disord. 2009;9(1):7-15.
Ali BH, Blunden G, Tanira MO, Nemmar A. Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): a review of recent research. Food and chemical Toxicology. 2008;46(2):409-20.
Matsuda A, Wang Z, Takahashi S, Tokuda T, Miura N, Hasegawa J. Upregulation of mRNA of retinoid binding protein and fatty acid binding protein by cholesterol enriched-diet and effect of ginger on lipid metabolism. Life sciences. 2009;84(25):903-7.
Kadnur SV, Goyal RK. Beneficial effects of Zingiber officinale Roscoe on fructose induced hyperlipidemia and hyperinsulinemia in rats. Indian journal of experimental biology. 2005;43(12):1161.
Alizadeh-Navaei R, Roozbeh F, Saravi M, Pouramir M, Jalali F, Moghadamnia AA. Investigation of the effect of ginger on the lipid levels. A double blind controlled clinical trial. Saudi medical journal. 2008;29(9):1280-4.
Bordia A, Verma S, Srivastava K. Effect of ginger (Zingiber officinale Rosc.) and fenugreek (Trigonella foenumgraecum L.) on blood lipids, blood sugar and platelet aggregation in patients with coronary artery disease. Prostaglandins, Leukotrienes and Essential Fatty Acids. 1997;56(5):379-84.
D. Moher AL, J. Tetzlaff, D.G. Altman, PRISMA Group. Preferredreporting items for systematic reviews and meta-analyses: the PRISMAstatement. BMJ 339. 2009;b2535.
Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Controlled clinical trials. 1996;17(1):1-12.
Marik PE, Zaloga GP. Meta-analysis of parenteral nutrition versus enteral nutrition in patients with acute pancreatitis. Bmj. 2004;328(7453):1407.
Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. Bmj. 1997;315(7109):629-34.
Andallu B, Radhika B, Suryakantham V. Effect of aswagandha, ginger and mulberry on hyperglycemia and hyperlipidemia. Plant Foods for Human Nutrition. 2003;58(3):1-7.
Mahluji S, Attari VE, Mobasseri M, Payahoo L, Ostadrahimi A, Golzari SE. Effects of ginger (Zingiber officinale) on plasma glucose level, HbA1c and insulin sensitivity in type 2 diabetic patients. International journal of food sciences and nutrition. 2013;64(6):682-6.
Atashak S, Peeri M, Jafari A, Azarbayjani MA. Effects of ginger supplementation and resistance training on lipid profiles and body composition in obese men. Journal of Medicinal Plants Research. 2011;5(16):3827-32.
Tabibi H, Imani H, Atabak S, Najafi I, Hedayati M, Rahmani L. EFFECTS OF GINGER ON SERUM LIPIDS AND LIPOPROTEINS IN PERITONEAL DIALYSIS PATIENTS: A RANDOMIZED CONTROLLED TRIAL. Peritoneal Dialysis International. 2015:pdi. 2015.00006.
Arablou T, Aryaeian N, Valizadeh M, Sharifi F, Hosseini A, Djalali M. The effect of ginger consumption on glycemic status, lipid profile and some inflammatory markers in patients with type 2 diabetes mellitus. International journal of food sciences and nutrition. 2014;65(4):515-20.
Azimi P, Ghiasvand R, Feizi A, Hariri M, Abbasi B. Effects of Cinnamon, Cardamom, Saffron, and Ginger Consumption on Markers of Glycemic Control, Lipid Profile, Oxidative Stress, and Inflammation in Type 2 Diabetes Patients. The review of diabetic studies: RDS. 2013;11(3-4):258-66.
Gao H, Guan T, Li C, Zuo G, Yamahara J, Wang J, et al. Treatment with ginger ameliorates fructose-induced Fatty liver and hypertriglyceridemia in rats: modulation of the hepatic carbohydrate response element-binding protein-mediated pathway. Evidence-Based Complementary and Alternative Medicine. 2012;2012.
Fuhrman B, Rosenblat M, Hayek T, Coleman R, Aviram M. Ginger extract consumption reduces plasma cholesterol, inhibits LDL oxidation and attenuates development of atherosclerosis in atherosclerotic, apolipoprotein E-deficient mice. The Journal of nutrition. 2000;130(5):1124-31.
Srinivasan K, Sambaiah K. The effect of spices on cholesterol 7 alpha-hydroxylase activity and on serum and hepatic cholesterol levels in the rat. International journal for vitamin and nutrition research Internationale Zeitschrift fur Vitamin-und Ernahrungsforschung Journal international de vitaminologie et de nutrition. 1990;61(4):364-9.
Ness GC, Zhao Z, Lopez D. Inhibitors of cholesterol biosynthesis increase hepatic low-density lipoprotein receptor protein degradation. Archives of biochemistry and biophysics. 1996;325(2):242-8.
Liu N, Huo G, Zhang L, Zhang X. [Effect of Zingiber OfficinaleRosc on lipid peroxidation in hyperlipidemia rats]. Wei sheng yan jiu= Journal of Hygiene Research. 2003;32(1):22-3.
Platel K, Srinivasan K. Influence of dietary spices or their active principles on digestive enzymes of small intestinal mucosa in rats. International journal of food sciences and nutrition. 1996;47(1):55-9.
Hashimoto K, Satoh K, Murata P, Makino B, Sakakibara I, Kase Y, et al. Component of Zingiber officinale that improves the enhancement of small intestinal transport. Planta medica. 2002;68(10):936-9.
Han L-K, Gong X-J, Kawano S, Saito M, Kimura Y, Okuda H. [Antiobesity actions of Zingiber officinale Roscoe]. Yakugaku zasshi: Journal of the Pharmaceutical Society of Japan. 2005;125(2):213-7.
Fuhrman B, Judith O, Keidar S, Ben-Yaish L, Kaplan M, Aviram M. Increased uptake of LDL by oxidized macrophages is the result of an initial enhanced LDL receptor activity and of a further progressive oxidation of LDL. Free Radical Biology and Medicine. 1997;23(1):34-46.
Thomson M, Al-Qattan K, Al-Sawan S, Alnaqeeb M, Khan I, Ali M. The use of ginger (Zingiber officinale Rosc.) as a potential anti-inflammatory and antithrombotic agent. Prostaglandins, leukotrienes and essential fatty acids. 2002;67(6):475-8.
Al-Amin ZM, Thomson M, Al-Qattan KK, Peltonen-Shalaby R, Ali M. Anti-diabetic and hypolipidaemic properties of ginger (Zingiber officinale) in streptozotocin-induced diabetic rats. British Journal of Nutrition. 2006;96(4):660-6.
Bhandari U, Pillai K. Effect of ethanolic extract of Zingiber officinale on dyslipidaemia in diabetic rats. Journal of ethnopharmacology. 2005;97(2):227-30.
ElRokh E-SM, Yassin NA, El-Shenawy SM, Ibrahim BM. Antihypercholesterolaemic effect of ginger rhizome (Zingiber officinale) in rats. Inflammopharmacology. 2010;18(6):309-15.
Goyal RK, Kadnur SV. Beneficial effects of Zingiber officinale on goldthioglucose induced obesity. Fitoterapia. 2006;77(3):160-3.
Nammi S, Sreemantula S, Roufogalis BD. Protective Effects of Ethanolic Extract of Zingiber officinale Rhizome on the Development of Metabolic Syndrome in High‐Fat Diet‐Fed Rats. Basic & clinical pharmacology & toxicology. 2009;104(5):366-73.
Sharma I, Gusain D, Dixit V. Hypolipidaemic and antiatherosclerotic effects of plumbagin in rabbits. Indian journal of physiology and pharmacology. 1991;35(1):10-4.
Submission of a manuscript implies: that the work described has not been published before; that it is not under consideration for publication anywhere else; that its publication has been approved by all co-authors, if any, as well as by the responsible authorities – tacitly or explicitly – at the institute where the work has been carried out. The publisher will not be held legally responsible should there be any claims for compensation. Authors wishing to include figures, tables, or text passages that have already been published elsewhere are required to obtain permission from the copyright owner(s) for both the print and online format and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate from the authors.
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. This work is licensed under a Creative Commons license (CC-BY). However, the license permits any user to read, copy, redistribute and and make derivative the material in any medium or format for any purpose, even commercially.
